SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-016122
Filing Date
2022-11-03
Accepted
2022-11-03 07:00:39
Documents
72
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q elev-20220930x10q.htm   iXBRL 10-Q 2032263
2 EX-4.1 elev-20220930xex4d1.htm EX-4.1 182160
3 EX-10.1 elev-20220930xex10d1.htm EX-10.1 645261
4 EX-10.2 elev-20220930xex10d2.htm EX-10.2 389091
5 EX-31.1 elev-20220930xex31d1.htm EX-31.1 11004
6 EX-31.2 elev-20220930xex31d2.htm EX-31.2 10896
7 EX-32 elev-20220930xex32.htm EX-32 7560
8 GRAPHIC elev-20220930xex10d2001.jpg GRAPHIC 939
  Complete submission text file 0001558370-22-016122.txt   8358752

Data Files

Seq Description Document Type Size
9 EX-101.SCH elev-20220930.xsd EX-101.SCH 44192
10 EX-101.CAL elev-20220930_cal.xml EX-101.CAL 38483
11 EX-101.DEF elev-20220930_def.xml EX-101.DEF 185419
12 EX-101.LAB elev-20220930_lab.xml EX-101.LAB 440982
13 EX-101.PRE elev-20220930_pre.xml EX-101.PRE 338046
66 EXTRACTED XBRL INSTANCE DOCUMENT elev-20220930x10q_htm.xml XML 1000703
Mailing Address 888 SEVENTH AVE 12TH FLOOR NEW YORK NY 10106
Business Address 888 SEVENTH AVE 12TH FLOOR NEW YORK NY 10106 212-651-6380
Elevation Oncology, Inc. (Filer) CIK: 0001783032 (see all company filings)

IRS No.: 841771427 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40523 | Film No.: 221356110
SIC: 2836 Biological Products, (No Diagnostic Substances)